ID: ALA86803

Max Phase: Preclinical

Molecular Formula: C23H26N2O5S

Molecular Weight: 442.54

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc([C@H]2CC[C@@H](C(=O)O)N2C(=O)CNC(=O)[C@@H](S)Cc2ccc(O)cc2)cc1

Standard InChI:  InChI=1S/C23H26N2O5S/c1-14-2-6-16(7-3-14)18-10-11-19(23(29)30)25(18)21(27)13-24-22(28)20(31)12-15-4-8-17(26)9-5-15/h2-9,18-20,26,31H,10-13H2,1H3,(H,24,28)(H,29,30)/t18-,19+,20+/m1/s1

Standard InChI Key:  CDOJKZDWTVBCIP-AABGKKOBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 442.54

Molecular Weight (Monoisotopic): 442.1562

AlogP: 2.47

#Rotatable Bonds: 7

Polar Surface Area: 106.94

Molecular Species: ACID

HBA: 5

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.91

CX Basic pKa:

CX LogP: 2.85

CX LogD: -0.36

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.49

Np Likeness Score: -0.22

References

1. Fournie-Zaluski MC, Coric P, Thery V, Gonzalez W, Meudal H, Turcaud S, Michel JB, Roques BP..  (1996)  Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.,  39  (13): [PMID:8691458] [10.1021/jm950783c]

Source

Source(1):

• Scientific Literature